Blood doping blood doping. Experimental evidence, however, has shown that cobalamin has no effect on erythropoiesis in the absence of a red blood cell/oxygen deficiency. These results seem to confirm much of what is already known about the functioning of cobalamin. The signaling pathway that induces erythropoietin secretion and subsequently red blood cell manufacture using cobalamin is O dependent. Erythropoietin is only secreted in the kidneys when there is an O deficiency, as such, RBC manufacture is independent of the amount of cobalamin administered when there is no O deficiency. Accordingly, cobalamin is of little to no value in blood doping. More
What a Beautiful Name What a Beautiful Name "What a Beautiful Name" is a song by Australian praise and worship group Hillsong Worship. The song, written and led by Brooke Ligertwood and co-written with Ben Fielding, refers to the promise of salvation through Jesus Christ as represented by His Holy Name. The "genre-smashing single" contributed to Hillsong being named "Billboard"s Top Christian Artist of 2017. "What a Beautiful Name" won two Dove Awards for Song of the Year and Worship Song of the Year in 2017. It won the 2018 Grammy Award for Best Contemporary Christian Music Performance/Song. "What a Beautiful Name" was released